Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Canadian North York General Hospital Chooses Enterprise Imaging Solution from Sectra to Improve Radiology Workflows
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with North […]
Sectra Speeds Up Clinical Use of AI -- Digital Pathology Apps Now Available in Marketplace
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) expands its AI marketplace with digital pathology. […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more